Insider · CIK 0001293973
Ehrlich Christopher B
Reports to the SEC for 10 companies · SOUTH SAN FRANCISCO, CA
Transactions
50
Companies
10
Filings
10
CIK
0001293973
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-07 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-05-30 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-03-04 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-02-24 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-12-02 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-09-30 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-09-25 | CEROCERO THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion | — |
| 2024-09-25 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockM Exercise/Conversion | −$275K |
| 2024-06-13 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2024-03-25 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-02-19 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Convertible Promissory NoteM Exercise/Conversion | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockM Exercise/Conversion | +$1.56M |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockJ Other | −$1.56M |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockJ Other | +$175K |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockA Award | +$100K |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · WarrantsJ Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · WarrantsJ Other | — |
| 2023-06-22 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-01-20 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-10-04 | eFFECTOR Therapeutics, Inc.P Purchase | +$197.22 |
| 2022-09-26 | eFFECTOR Therapeutics, Inc.P Purchase | +$10.4K |
| 2022-06-09 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-02-18 | eFFECTOR Therapeutics, Inc.P Purchase | +$4,300 |
| 2022-02-14 | eFFECTOR Therapeutics, Inc.P Purchase | +$8,900 |
| 2022-02-09 | eFFECTOR Therapeutics, Inc.P Purchase | +$4,750 |
| 2022-02-08 | eFFECTOR Therapeutics, Inc.P Purchase | +$4,920 |
| 2022-02-04 | eFFECTOR Therapeutics, Inc.P Purchase | +$5,000 |
| 2022-02-03 | eFFECTOR Therapeutics, Inc.P Purchase | +$25.8K |
| 2022-01-27 | eFFECTOR Therapeutics, Inc.P Purchase | +$26.5K |
| 2021-10-08 | CEROCERO THERAPEUTICS HOLDINGS, INC. · WarrantsJ Other | — |
| 2021-10-08 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Class B Common StockJ Other | — |
| 2021-10-08 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | +$367K |
| 2021-10-06 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.C Conversion | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.C Conversion | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.Class B Common StockD Disposition to Issuer | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.Class B Common StockC Conversion | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.Class B Common StockD Disposition to Issuer | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.Class B Common StockC Conversion | — |
| 2021-01-12 | eFFECTOR Therapeutics, Inc.Class B Common StockJ Other | — |
| 2013-04-10 | Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award | — |
| 2013-03-01 | BIOMIMETIC THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer | — |
| 2013-03-01 | BIOMIMETIC THERAPEUTICS, INC.D Disposition to Issuer | — |
| 2013-03-01 | BIOMIMETIC THERAPEUTICS, INC.D Disposition to Issuer | — |
| 2013-03-01 | BIOMIMETIC THERAPEUTICS, INC.D Disposition to Issuer | — |
Recent filings
- 4Ehrlich Christopher B0001213900-26-002952SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-25-050116SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-25-021180SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-25-017515SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-24-105730SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-24-084830SEC(opens sec.gov)
- 4Ehrlich Christopher B0000950170-24-073204SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-24-026821SEC(opens sec.gov)
- 4Ehrlich Christopher B0001209191-24-003702SEC(opens sec.gov)
- 4Ehrlich Christopher B0001213900-24-015026SEC(opens sec.gov)
Companies
- ANESIVA, INC.10% Owner
- BIOMIMETIC THERAPEUTICS, INC.Director
- CERO THERAPEUTICS HOLDINGS, INC.Director, Chairman and CEOCERO
- eFFECTOR Therapeutics, Inc.Director
- INTRALASE CORP10% Owner
- Launch One Acquisition Corp.Director, Chief Executive OfficerLPAA
- MYOGEN INC10% Owner
- Paratek Pharmaceuticals, Inc.Director
- TESARO, Inc.10% Owner
- Trius Therapeutics IncVenture Member
Address
CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY, SUITE 230
SOUTH SAN FRANCISCO, CA, 94080